Drugs known as antidepressants target the serotonin transporter in nerve cells and are among the most commonly prescribed medicines worldwide, but are sometimes associated with significant side effects.
Numinus Wellness Closes $6 Million Dollar Bought Deal
The TDR Three Key Takeaways: Capital Raise: Numinus Wellness Inc. raised $6 million through a public offering to support its psychedelic-assisted therapy projects. Strategic Advising: